What Happened?
South San Francisco, CA-based Walking Fish Therapeutics Appointed Nallakkan Arvindan as Chief Technology Officer
About the Company
Walking Fish Therapeutics, Inc. is a privately held biotechnology company discovering and developing innovative therapeutics that harness the power of B cells as protein factories and immune modulators. Walking Fish has created a broad technology platform addressing enzyme replacement therapies, oncology, autoimmune disease, and recombinant antibody production. The company`s first program, WFX-001, employs B cells as protein factories to generate a deficient enzyme in Fabry disease. Founded in 2019 by Lewis (Rusty) Williams, MD, PhD, the former CSO of Chiron, co-founder of Cor Therapeutics and founder and Chief Executive Officer of Five Prime Therapeutics, the company has assembled a diverse and experienced team of scientists and business leaders who are committed to bringing life-changing and life-saving therapeutics to patients worldwide.
About the Person
Nallakkan Arvindan is Chief Technology Officer at Walking Fish Therapeutics. Previously, Nallakkan held various senior IT leadership roles in the industry.
Info Source
News
Short Profile